Determination of Delafloxacin in Pharmaceutical Formulations Using a Green RP-HPTLC and NP-HPTLC Methods: A Comparative Study

In this work; delafloxacin (DLFX) was determined using a validated green RP-HPTLC and NP-HPTLC methods in commercial tablets and in-house developed solid lipid nanoparticles (SLNs). RP-HPTLC determination of DLFX was performed using “RP-18 silica gel 60 F254S HPTLC plates”. However; NP-HPTLC estimat...

Descripción completa

Detalles Bibliográficos
Autores principales: Alam, Prawez, Ezzeldin, Essam, Iqbal, Muzaffar, Mostafa, Gamal A.E., Anwer, Md. Khalid, Alqarni, Mohammed H., Foudah, Ahmed I., Shakeel, Faiyaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344820/
https://www.ncbi.nlm.nih.gov/pubmed/32630451
http://dx.doi.org/10.3390/antibiotics9060359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344820/
https://www.ncbi.nlm.nih.gov/pubmed/32630451
http://dx.doi.org/10.3390/antibiotics9060359

Ejemplares similares